NCT03944265View on ClinicalTrials.gov

Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 8, 2019

Primary Completion Date

December 1, 2020

Study Completion Date

December 31, 2020

Conditions
Activating ALK Gene Mutation NegativeActivating EGFR Gene Mutation NegativeActivating ROS1 Gene Mutation NegativeHealth Care ProviderLung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Stage IVB Lung Cancer AJCC v8
Interventions
OTHER

Counseling

Participate in treatment decision counseling session

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Medical Chart Review

Ancillary studies

Trial Locations (1)

19107

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER

NCT03944265 - Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter